Analytical Data
-
基因名
LBP
- Application
-
别名
LBP;Lipopolysaccharide-binding Protein
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P18428
-
表达区间
26-481aa
-
氨基酸序列
ANPGLVARITDKGLQYAAQEGLLALQSELLRITLPDFTGDLRIPHVGRGR YEFHSLNIHSCELLHSALRPVPGQGLSLSISDSSIRVQGRWKVRKSFFKL QGSFDVSVKGISISVNLLLGSESSGRPTVTASSCSSDIADVEVDMSGDLG WLLNLFHNQIESKFQKVLESRICEMIQKSVSSDLQPYLQTLPVTTEIDSF ADIDYSLVEAPRATAQMLEVMFKGEIFHRNHRSPVTLLAAVMSLPEEHNK MVYFAISDYVFNTASLVYHEEGYLNFSITDDMIPPDSNIRLTTKSFRPFV PRLARLYPNMNLELQGSVPSAPLLNFSPGNLSVDPYMEIDAFVLLPSSSK EPVFRLSVATNVSATLTFNTSKITGFLKPGKVKVELKESKVGLFNAELLE ALLNYYILNTFYPKFNDKLAEGFPLPLLKRVQLYDLGLQIHKDFLFLGAN VQYMRV
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of LBP (Lipoprotein Binding Protein) recombinant proteins has gained significant attention due to their crucial roles in various biological processes and potential applications in medicine and biotechnology. LBP plays a vital role in lipid metabolism and host defense by facilitating the transport of lipids, including lipopolysaccharides (LPS), which are key components of bacterial membranes. The ability of LBP to modulate immune responses to infections makes it an attractive target for therapeutic interventions, particularly in conditions characterized by inflammatory responses. With advancements in recombinant DNA technology, producing LBP in large quantities has become feasible, enabling researchers to explore its structure-function relationships and biological activities more comprehensively. The recombinant form allows for the manipulation of the protein to enhance its properties, making it suitable for various applications, including drug development, vaccine formulation, and diagnostic tools. Moreover, understanding the molecular mechanisms by which LBP interacts with pathogens and modulates immune responses could lead to the development of novel strategies for treating infectious diseases and chronic inflammatory conditions. Therefore, research on LBP recombinant proteins not only provides insights into fundamental biological processes but also opens up potential avenues for innovative therapeutic solutions. As the field continues to evolve, the implications of LBP research hold promise for advancing our understanding of lipid-related diseases and improving public health outcomes.












